Eurofarma is the pharmaceutical where collaborators are the most satisfied with their salaries
Published in: February 3, 2017
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, February 2017 – Eurofarma was acknowledged as the pharmaceutical with most satisfied collaborators when it comes to remuneration and benefits, indicated annual survey by portal Love Mondays.
The company obtained 4.57 average grade with 5 as the maximum grade. Over 200 thousand spontaneous assessments were made by professionals from over 70 thousand companies from 15 different sectors.
In order to participate in the ranking, companies should have, at least, 20 assessments, and for the creation of each sector’s list, at least 10 companies were assessed. It’s worth reminding that Eurofarma is present also in the list of the 50 Most Beloved Companies in Brazil, another survey by portal Love Mondays.
About Eurofarma Group
Eurofarma Group is the first Brazilian multinational pharmaceutical with 100% national capital. Acknowledged by the medical community and society for promoting access to health and quality of life with treatments at fair prices, with quality and innovation, is present in 20 countries.
With 45 years of existence and 6,500 collaborators, its position is outstanding in the segments where it operates: Medical Prescription and Over-the-counter, Generic, Hospital, Biddings, Oncology, and Services to Third Parties. Its portfolio comprises over 280 products and, in 2016, over 290 million units of medication were produced. Last year, the Group reached income of R$ 3.3 billion, 15.7% higher than in the previous year.
In 2016, with R$ 141 million in investments and its expertise and agility in Research and Development, it became the pharmaceutical with best performance in portfolio renovation, counting, today, on 176 projects in the pipeline.
For further information, access www.eurofarma.com.br
Information to Press
G&A Public Relations – Clareane Moraes | (11) 3065-3045 | clareane@gaspar.com.br Guilherme Gaspar | (11) 3065-3049 | guilherme@gaspar.com.br
The company obtained 4.57 average grade with 5 as the maximum grade. Over 200 thousand spontaneous assessments were made by professionals from over 70 thousand companies from 15 different sectors.
In order to participate in the ranking, companies should have, at least, 20 assessments, and for the creation of each sector’s list, at least 10 companies were assessed. It’s worth reminding that Eurofarma is present also in the list of the 50 Most Beloved Companies in Brazil, another survey by portal Love Mondays.
About Eurofarma Group
Eurofarma Group is the first Brazilian multinational pharmaceutical with 100% national capital. Acknowledged by the medical community and society for promoting access to health and quality of life with treatments at fair prices, with quality and innovation, is present in 20 countries.
With 45 years of existence and 6,500 collaborators, its position is outstanding in the segments where it operates: Medical Prescription and Over-the-counter, Generic, Hospital, Biddings, Oncology, and Services to Third Parties. Its portfolio comprises over 280 products and, in 2016, over 290 million units of medication were produced. Last year, the Group reached income of R$ 3.3 billion, 15.7% higher than in the previous year.
In 2016, with R$ 141 million in investments and its expertise and agility in Research and Development, it became the pharmaceutical with best performance in portfolio renovation, counting, today, on 176 projects in the pipeline.
For further information, access www.eurofarma.com.br
Information to Press
G&A Public Relations – Clareane Moraes | (11) 3065-3045 | clareane@gaspar.com.br Guilherme Gaspar | (11) 3065-3049 | guilherme@gaspar.com.br